Labat Africa (JSE:LAB) 3-Year RORE % : -694.87% (As of Nov. 2025)


What is Labat Africa 3-Year RORE %?

Labat Africa JSE:LAB 3-Year RORE % is -694.87 as of Nov. 2025. The stock has 5 warning signs investors should review. Among 935 Drug Manufacturers companies, Labat Africa ranks worse than 98.82% on this metric.

Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments. Labat Africa's 3-Year RORE % for the quarter that ended in Nov. 2025 was -694.87%.

The industry rank for Labat Africa's 3-Year RORE % or its related term are showing as below:

JSE:LAB's 3-Year RORE % is ranked worse than
98.82% of 935 companies
in the Drug Manufacturers industry
Industry Median: 2.86 vs JSE:LAB: -694.87

Labat Africa  (JSE:LAB) 3-Year RORE % Explanation

Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.

There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.

Be Aware

Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.


Labat Africa 3-Year RORE % Related Terms


Labat Africa 3-Year RORE % Historical Data

* Premium members only.

The historical data trend for Labat Africa's 3-Year RORE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Labat Africa 3-Year RORE % Chart

Labat Africa Annual Data
Trend Feb14 Feb15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 May23 May24
3-Year RORE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 145.95 10.47 -70.14 0.00 0.00

Labat Africa Semi-Annual Data
Aug15 Aug16 Feb17 Aug17 Feb18 Aug18 Feb19 Aug19 Feb20 Aug20 Feb21 Aug21 Feb22 Nov22 May23 Nov23 May24 Nov24 May25 Nov25
3-Year RORE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 -2.34 -345.21 -694.87

JSE:LAB vs ZTS, UTHR, VTRS: 3-Year RORE % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Labat Africa's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Labat Africa 3-Year RORE % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Labat Africa's 3-Year RORE % distribution charts can be found below:

* The bar in red indicates where Labat Africa's 3-Year RORE % falls into.



Labat Africa 3-Year RORE % Calculation

Labat Africa's 3-Year RORE % for the quarter that ended in Nov. 2025 is calculated as:

3-Year RORE %=( Most Recent EPS (Diluted)- First Period EPS (Diluted) )/( Cumulative EPS (Diluted) for 3-year -Cumulative Dividends per Share for 3-year )
=( 0.134--0.137 )/( -0.039-0 )
=0.271/-0.039
=-694.87 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Nov. 2025 and 3-year before.

Frequently Asked Questions Learn more about 3-Year RORE % →
What does a 3-Year RORE % of -694.87 mean?
Labat Africa (JSE:LAB) has a 3-Year RORE % of -694.87 as of Nov. 2025. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Labat Africa and its competitors. According to the industry distribution chart, Labat Africa ranks #924 out of 935 companies in the Drug Manufacturers industry, placing it in the top 98.8%.
Is Labat Africa's 3-Year RORE % too high?
Labat Africa's current 3-Year RORE % is -694.87. Based on the distribution chart, Labat Africa ranks #924 out of 935 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers.
How does Labat Africa's 3-Year RORE % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Labat Africa ranks #924 out of 935 companies for 3-Year RORE %. This places Labat Africa in the lower half of its industry. The industry median 3-Year RORE % is 2.86. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year RORE % for a Drug Manufacturers company?
The median 3-Year RORE % among Drug Manufacturers companies is 2.86, based on 935 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year RORE % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year RORE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year RORE % mean?
A high 3-Year RORE % can signal that a stock is expensive relative to its fundamentals. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Labat Africa and its competitors. For the Drug Manufacturers industry, the median 3-Year RORE % is 2.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Labat Africa's current 3-Year RORE % is -694.87. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Labat Africa stock overvalued right now?
Based on GuruFocus' analysis, Labat Africa (JSE:LAB) is currently considered Possible Value Trap. The stock's GF Value™ is R0.22, compared to a current price of R0.05 — trading 77.3% below its estimated fair value. The current 3-Year RORE % is -694.87. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year RORE % calculated?
3-Year RORE % is calculated from a company's financial statements. For Labat Africa (JSE:LAB), the current 3-Year RORE % is -694.87 as of Nov. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Labat Africa Business Description

Other Exchanges LAO:Germany
Address 75 Maude StreetSandown, The Leonardo 14th Floor, Sandown, Johannesburg, GT, ZAF, 1709
Labat Africa Ltd is an investment holding company. Through its subsidiaries, the company operates in the following segments; Technology, Head office, and Healthcare. The Technology segment manufactures and distributes integrated circuits South African Micro - Electronic Systems. Head office operations provide management services, logistics and seeks further investment opportunities for the Group. The Healthcare segment generates maximum revenue for the company and focusses on medical cannabis industry in South Africa. Geographically, the company carries out its business operations in South Africa.